According to CoinMeta, the price of Injective ( INJ ) increased by 6% after its listing on NASDAQ and the INJ ETF ( INJC ) was pledged. This ETF provides investors with direct exposure to the tokens and potential pledge rewards. According to NASDAQ's official listing notice and the latest SEC prospectus, this new fund is intended to directly hold INJ while seeking additional returns through pledge rewards. This sets it apart from simple spot-style crypto funds, as the trust not only tracks the market price of the tokens but also participates in the proof-of-stake system of the Injective network. This listing brings Injective closer to the mainstream investment infrastructure used by traditional stocks and ETF buyers. According to the prospectus, the main goal of the trust is to provide exposure to the price of INJ, with the secondary goal of earning more INJ through pledges. In fact, this means that investors are purchasing two value drivers: the tokens themselves and the earnings generated by helping to verify transactions on the network. This structure adds a new chapter to the broader trend of altcoins ETF that has already been seen in products related to Solana and other digital assets.